Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
46
TCBK Quote, Financials, Valuation and Earnings
Last price:
$40.82
Seasonality move
:
1.31%
Day range:
$40.72 - $42.45
52-week range:
$31.73 - $51.06
Dividend yield:
3.23%
P/E ratio:
11.82x
P/S ratio:
3.49x
P/B ratio:
1.10x
Volume:
98K
Avg. volume:
100.7K
1-year change:
18.53%
Market cap:
$1.3B
Revenue:
$388.8M
EPS (TTM):
$3.46
Analysts' Opinion
-
Consensus RatingTriCo Bancshares has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $50.33, TriCo Bancshares has an estimated upside of 23.13% from its current price of $40.88.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $46.00 representing 100% downside risk from its current price of $40.88.
Fair Value
-
According to the consensus of 4 analysts, TriCo Bancshares has 23.13% upside to fair value with a price target of $50.33 per share.
TCBK vs. S&P 500
-
Over the past 5 trading days, TriCo Bancshares has underperformed the S&P 500 by -0.39% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
TriCo Bancshares does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
TriCo Bancshares revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter TriCo Bancshares reported revenues of $98.6M.
Earnings Growth
-
TriCo Bancshares has grown year-over-year earnings for 1 quarter straight. In the most recent quarter TriCo Bancshares reported earnings per share of $0.88.
Enterprise value:
1.4B
EV / Invested capital:
0.98x
Price / LTM sales:
3.49x
EV / EBIT:
4.77x
EV / Revenue:
3.56x
PEG ratio (5yr expected):
--
EV / Free cash flow:
13.18x
Price / Operating cash flow:
12.92x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
1.17%
Net Income Margin (TTM):
29.55%
Return On Equity:
9.64%
Return On Invested Capital:
7.1%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $402.5M | $411.1M | $388.8M | $100.8M | $98.6M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $3.81 | $3.52 | $3.46 | $0.78 | $0.88 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.1B | $3B | $2.6B | $2.3B | $194.4M | |
| Total Assets | $7.6B | $8.6B | $9.9B | $9.9B | $9.7B | |
| Current Liabilities | $1.4M | $928K | $1.2M | $8.4M | $11.5M | |
| Total Liabilities | $6.7B | $7.6B | $8.9B | $8.8B | $8.5B | |
| Total Equity | $925.1M | $1B | $1B | $1.2B | $1.2B | |
| Total Debt | $84.5M | $108.2M | $365.6M | $733.7M | $190.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $162.9M | $138.9M | $109.7M | $36.5M | $24.2M | |
| Cash From Investing | -$723.2M | $28.6M | $285M | $42.2M | -$60M | |
| Cash From Financing | -$100.9M | -$176M | -$348.5M | -$91.1M | -$139.4M | |
| Free Cash Flow | $159.3M | $134M | $105.2M | $35.5M | $22.9M | |
TCBK
Sector
Market Cap
$1.3B
$618.6M
Price % of 52-Week High
80.06%
85.59%
Dividend Yield
3.23%
2.01%
Shareholder Yield
10.32%
3.87%
1-Year Price Total Return
18.53%
9.44%
Beta (5-Year)
0.549
0.715
Dividend yield:
3.23%
Annualized payout:
$1.32
Payout ratio:
38%
Growth streak:
12 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$41.13
200-day SMA
Sell
Level
$43.15
Bollinger Bands (100)
Sell
Level
42.35 - 47.19
Chaikin Money Flow
Buy
Level
8M
20-day SMA
Sell
Level
$42.80
Relative Strength Index (RSI14)
Sell
Level
35.99
ADX Line
Sell
Level
20.61
Williams %R
Buy
Level
-80.1956
50-day SMA
Sell
Level
$43.21
MACD (12, 26)
Sell
Level
-0.89
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
3.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.3626)
Sell
CA Score
(Annual)
Level (-2.0542)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (1.9199)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.
Stock Forecast FAQ
In the current month, TCBK has received 1 Buy ratings 3 Hold ratings, and 0 Sell ratings. The TCBK average analyst price target in the past 3 months is $50.33.
-
Where Will TriCo Bancshares Stock Be In 1 Year?
According to analysts, the consensus estimate is that TriCo Bancshares share price will rise to $50.33 per share over the next 12 months.
-
What Do Analysts Say About TriCo Bancshares?
Analysts are divided on their view about TriCo Bancshares share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that TriCo Bancshares is a Sell and believe this share price will drop from its current level to $46.00.
-
What Is TriCo Bancshares's Price Target?
The price target for TriCo Bancshares over the next 1-year time period is forecast to be $50.33 according to 4 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is TCBK A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for TriCo Bancshares is a Hold. 3 of 4 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TCBK?
You can purchase shares of TriCo Bancshares via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase TriCo Bancshares shares.
-
What Is The TriCo Bancshares Share Price Today?
TriCo Bancshares was last trading at $40.82 per share. This represents the most recent stock quote for TriCo Bancshares. Yesterday, TriCo Bancshares closed at $40.88 per share.
-
How To Buy TriCo Bancshares Stock Online?
In order to purchase TriCo Bancshares stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
